Collaborative Studies Validating Transgenomic, Inc. (TBIO)’s ICE COLD-PCR Technology Highlighted In Educational Materials At Major Upcoming Cancer Meeting
5/29/2014 8:11:10 AM
Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that educational materials discussing its ICE COLD-PCR (ICP) technology will be available at its booth at the 2014 ASCO Annual Meeting.
Help employers find you! Check out all the jobs and post your resume.
comments powered by